arrow
K

Keertan Dheda

centre for lung infection and immunity
H指数:95
被引数:4.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Tongue Swab Mycobacterium tuberculosis Quantitative Polymerase Chain Reaction for Community Screening of Asymptomatic Tuberculosis Versus Clinic-Based Triage of Symptomatic Tuberculosis

舌拭子结核分枝杆菌定量聚合酶链反应用于社区无症状结核病筛查与基于诊所的有症状结核病分诊

2026-10-090
OAAI
Inflammatory biomarkers of asymptomatic and symptomatic tuberculosis

无症状和有症状结核病的炎症生物标志物

2026-07-250
OA
Reply to Adzemovic et al

回复Adzemovic et al.

2025-05-050
OA
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-M™ adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trial
2024-12-120
OAAI
Diagnostic Performance of Unstimulated IFN-γ (IRISA-TB) for Pleural Tuberculosis: A Prospective Study in South Africa and India

非刺激性ifn-γ (IRISA-TB) 对胸膜结核的诊断性能: 南非和印度的一项前瞻性研究

2024-09-240
OAAI
Recent advances in the treatment of tuberculosis

结核病治疗的最新进展

2024-09-0113
OA
Utility of Cerebrospinal Fluid Unstimulated Interferon-Gamma (IRISA-TB) as a Same-Day Test for Tuberculous Meningitis in a Tuberculosis-Endemic, Resource-Poor Setting

在结核病流行,资源贫乏的环境中,脑脊液非刺激性干扰素-γ (IRISA-TB) 作为结核性脑膜炎的当日测试的效用

2024-08-291
OAAI
Target regimen profiles for tuberculosis treatment

结核病治疗的目标方案概况

2024-08-011
OAAI
Review of Current Tuberculosis Human Infection Studies for Use in Accelerating Tuberculosis Vaccine Development: A Meeting Report

用于加速结核病疫苗研发的当前结核病人类感染研究综述:会议报告

2024-05-063
OAAI
SARS-CoV-2 Viral Replication Persists in the Human Lung for Several Weeks after Symptom Onset

症状发作后,SARS-CoV-2病毒复制在人肺中持续数周

2024-04-016
OAAI
Multidrug-resistant tuberculosis

耐多药结核病

2024-03-2427
OA